Josh Hardman

editor and founder of Psychedelic Alpha

Josh Hardman on KCRW

The panel was concerned about the strength of the evidence, allegations of participant abuse, and ill-defined therapeutic protocols. It’s a step backwards for the psychedelic movement.

MDMA therapy for PTSD treatment? FDA panel says no

The panel was concerned about the strength of the evidence, allegations of participant abuse, and ill-defined therapeutic protocols. It’s a step backwards for the psychedelic movement.

from Press Play with Madeleine Brand

More from KCRW

When one in three people have an abnormal lab test, does it become a disease?

from Second Opinion

This week, writer and author of Splinters: Another Kind of Love Story, Leslie Jamison reflects on her childhood marriage fantasy and says when it comes to love and marriage we all…

from Life Examined

This week, cognitive scientist and professor of psychology at Yale University Lori Santos explains that negative emotions are very much part of the human experience and essential to…

from Life Examined

USAID is a powerhouse of humanitarianism and global security

from Second Opinion

As Congress debates cuts to Medicaid (the health insurance program for the poor and disabled) in order to deliver a tax cut to the wealthy, it risks a cascade of negative effects on…

from Second Opinion

This week, Jennifer Senior , New York Times opinion writer and author “ All Joy and No Fun: The Paradox of Modern Parenthood,” discusses the impact of having children on life…

from Life Examined

Hopefully, we’ve learned many lessons, but there is still lots to be learned.

from Second Opinion

Statistics can be intimidating. But before you decide to begin a treatment you should ask what the expected benefit will be to you.

from Second Opinion

Anthrax – an example of how the US Government has worked to stop the spread of disease

from Second Opinion